Model update
tumour
TUMOUR
In addition to the RMH score, the following covariates were considered for the model update: gender, age, ECOG performance status (PS), number of co-morbidities, number of prior therapies, aspartate aminotransferase (AST), platelets, haemoglobin, NLR, tumour classification, and whether they were treated with chemotherapy, immunotherapy, targeted therapy and/or vaccines. Significant variables (All statistical evaluations were made assuming a two-sided test at the 5% level of significance. Statistical analyses were conducted using STATA version 15.0. In addition, analyses of AUC(